
City Therapeutics is a biotechnology company pioneering next-generation RNA interference (RNAi)-based medicines. We are building a diversified pipeline of innovative therapies through advanced RNAi trigger molecule engineering and novel targeting technologies designed to expand the reach of RNAi beyond the liver. We are seeking passionate, collaborative, and courageous individuals to join our team as we work to transform scientific discoveries into meaningful medicines for patients.
The Senior Director, Clinical Development (Medical Director) will provide medical and scientific leadership for City Therapeutics’ clinical development programs. This individual will play a central role in shaping clinical development strategy and translating innovative RNAi science into well-designed, executable clinical programs.
The successful candidate will serve as the medical lead for one or more programs, with responsibility for clinical strategy, protocol development, study execution, data interpretation, and regulatory interactions. This individual will collaborate closely with Clinical Operations, Biometrics, Pharmacology, Toxicology, Regulatory Affairs, Translational Medicine, and other cross-functional partners.
This is an opportunity for an experienced physician-scientist to have a meaningful impact within a growing biotechnology company and help advance programs from early clinical development through key milestones, and regulatory approvals.
Location: This position is based in Cambridge, Massachusetts, and requires an onsite presence five days per week.
City Therapeutics is an equal opportunity employer. We are committed to building an inclusive workplace and consider qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity or expression, national origin, age, disability, veteran status, genetic information, or any other characteristic protected by applicable law.
City Therapeutics is accepting resumes/CVs from direct applicants only. Recruitment Agency inquiries or submissions will not be accepted at this time.
Compensation: The base salary range provided reflects our current estimate of what we anticipate paying for this position. Your actual base salary will be based on several factors, including relevant skills, experience, internal equity, relevant education or training and market dynamics. In addition, this role is eligible for an annual cash bonus and equity compensation. City Therapeutics offers a comprehensive and competitive benefits package including medical, dental, vision, life insurance, health and dependent care FSA accounts, HSA/HRA accounts with company contributions, in addition to a 401(k) with competitive company match. Per Year Salary Range: $255,000 to $290,000

Founded by pioneering executives and scientists in RNAi, City Therapeutics is advancing next-generation engineering of small interfering RNAs (siRNAs) – the “trigger” molecules that mediate RNAi – to improve and expand the reach of RNAi-based medicines. City’s mission is to build the leading next-generation RNAi therapeutics company, unlocking RNAi’s transformative potential to help patients with a wide range of diseases.